Skip to main content

Cardiol Therapeutics Inc.

CRDL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001702123

No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Cardiol Therapeutics Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of CRDL: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders41141+1
Shares5.39M15.2K4.97M−403.6K (−7.5%)
Value$10.8M$30.6K$9.85M−$950.3K (−8.8%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Cardiol Therapeutics Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CRDL in Q3 2024
InstitutionSharesValue% of portfolio
Wealthspire Advisors, LLC30,302$60.0K0.00%
Two Sigma Investments, LP24,666$48.8K0.00%
Two Sigma Securities, LLC16,916$33.5K0.00%
Jane Street Group, LLC14,759$29.4K0.00%
TownSquare Capital, LLC13,745$27.2K0.00%
Wealth Enhancement Advisory Services, LLC13,700$27.1K0.00%
LPL Financial LLC13,310$26.4K0.00%
JPMorgan Chase & Co2,500$4.95K0.00%
Central Trust Co400$7920.00%
Huntington National Bank241$4770.00%

Sold out (9)

Institutions that held Cardiol Therapeutics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of CRDL in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Laird Norton Trust Company, LLC100,000$202.0K
Arrowstreet Capital, Limited Partnership29,294$58.0K
Envestnet Asset Management Inc26,167$52.5K
Baader Bank INC29,028$34.4K
Atria Investments LLC11,165$22.6K
Verition Fund Management LLC11,109$22.4K
CIBC Private Wealth Group, LLC8,000$15.0K
Benjamin Edwards Inc875$2.00K
Toronto Dominion Bank803$1.62K

Not filed for Q3 2024 yet (1)

Institutions that held Cardiol Therapeutics Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRDL in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Private Ocean, LLC15,151$30.6K